HomeMLTX • NASDAQ
MoonLake Immunotherapeutics
$46.88
3.99%
-1.95 Today
After Hours:
$46.88
(0.00%)0.00
Closed: Jun 6, 4:00:13 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
-40M-20M0
Revenue
Net Income
Revenue
Net income
(USD)Mar 2025Y/Y change
Revenue
——
Operating expense
47.49M139.58%
Net income
-39.94M-192.14%
Net profit margin
——
Earnings per share
-0.63-186.36%
EBITDA
-47.11M-141.67%
Effective tax rate
-0.38%—
0200M400M
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD)Mar 2025Y/Y change
Cash and short-term investments
480.13M-12.23%
Total assets
511.26M-9.37%
Total liabilities
98.68M741.22%
Total equity
412.58M—
Shares outstanding
63.47M—
Price to book
7.61—
Return on assets
-24.00%—
Return on capital
-25.14%—
-100M0
Net Change in Cash
Net change in cash
(USD)Mar 2025Y/Y change
Net income
-39.94M-192.14%
Cash from operations
-38.14M-155.15%
Cash from investing
56.25M295.27%
Cash from financing
73.12M43.44%
Net change in cash
91.14M1,153.30%
Free cash flow
-25.47M-68.33%
Top loserStockUS listed securityCH headquartered
Previous close
$48.83
Day range
$46.73 - $49.81
Year range
$31.42 - $58.26
Market cap
3.01B USD
Avg Volume
569.49K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2020
Employees
100
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Main menu
Google apps